1. Jin, Su Hyun, Kim, Hyunsoo, Gu, Dong Ryun, Choi, Yongwon, Lee, Seoung Hoon. . Actin-binding LIM protein 1 regulates receptor activator of NF-κB ligand-mediated osteoclast differentiation and motility. In BMB reports, 51, 356-361. doi:. https://pubmed.ncbi.nlm.nih.gov/29921413/
2. Narahara, Haruna, Sakai, Eiko, Yamaguchi, Yu, Yoshida, Noriaki, Tsukuba, Takayuki. 2018. Actin binding LIM 1 (abLIM1) negatively controls osteoclastogenesis by regulating cell migration and fusion. In Journal of cellular physiology, 234, 486-499. doi:10.1002/jcp.26605. https://pubmed.ncbi.nlm.nih.gov/29904924/
3. Liu, Danping, Wang, Xiaoping, Liu, Ying, Zhang, Zhen, Lv, Peng. 2022. Actin-Binding LIM 1 (ABLIM1) Inhibits Glioblastoma Progression and Serves as a Novel Prognostic Biomarker. In Disease markers, 2022, 9516808. doi:10.1155/2022/9516808. https://pubmed.ncbi.nlm.nih.gov/36583064/
4. Ohsawa, Natsumi, Koebis, Michinori, Mitsuhashi, Hiroaki, Nishino, Ichizo, Ishiura, Shoichi. 2014. ABLIM1 splicing is abnormal in skeletal muscle of patients with DM1 and regulated by MBNL, CELF and PTBP1. In Genes to cells : devoted to molecular & cellular mechanisms, 20, 121-34. doi:10.1111/gtc.12201. https://pubmed.ncbi.nlm.nih.gov/25403273/
5. Stevens, Jonathan, Ermakov, Alexander, Braganca, Jose, Brown, Nigel A, Norris, Dominic P. 2010. Analysis of the asymmetrically expressed Ablim1 locus reveals existence of a lateral plate Nodal-independent left sided signal and an early, left-right independent role for nodal flow. In BMC developmental biology, 10, 54. doi:10.1186/1471-213X-10-54. https://pubmed.ncbi.nlm.nih.gov/20487527/
6. Chen, Xi, Huang, Yaping, Shi, Dianyu, Zou, Yu, Xie, Chun. 2020. LncRNA ZNF667-AS1 Promotes ABLIM1 Expression by Adsorbing micro RNA-1290 to Suppress Nasopharyngeal Carcinoma Cell Progression. In OncoTargets and therapy, 13, 4397-4409. doi:10.2147/OTT.S245554. https://pubmed.ncbi.nlm.nih.gov/32606725/
智鼠故事 
